Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
View All Featured ArticlesHeadline News
Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study
Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer
Olomorasib shows durable first-line activity in KRAS G12C-mutant lung cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
Presented by Jeff Doyle & Dr Paul Jeffers, Pfizer. Followed by Jonas Elfving, MKS
07th February 2017
New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process
Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019
Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product
Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC
30th November 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Amsphere TM A3
Lifetime study for JSR Amsphere A3 – protein A resin
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
